Skip to main content

ADVERTISEMENT

Ryan Lynch, MD

Ryan Lynch, MD, Fred Hutch Cancer Center
Videos
12/21/2023
At the 65th ASH Annual Meeting, Ryan C Lynch, MD, presented data on the high complete response rates of mosunetuzumab in previously untreated patients with follicular lymphoma and marginal zone lymphoma and only low-grade cytokine release...
At the 65th ASH Annual Meeting, Ryan C Lynch, MD, presented data on the high complete response rates of mosunetuzumab in previously untreated patients with follicular lymphoma and marginal zone lymphoma and only low-grade cytokine release...
At the 65th ASH Annual Meeting,...
12/21/2023
Oncology